Company’s PAT for FY22 was reported at Rs51.89 crore as compared to Rs28.78 crore in FY21, registering a growth of 80.30% yoy.
IPCA Laboratories slumped 2.27% to Rs 954.90 after the companys consolidated net profit fell 19.3% to Rs 130.23 crore despite of a 15.6% rise in net sales to Rs 1,289.10 crore in Q4 FY22 over Q4 FY21.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
